BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 15502843)

  • 1. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.
    Wang H; Liao H; Ochani M; Justiniani M; Lin X; Yang L; Al-Abed Y; Wang H; Metz C; Miller EJ; Tracey KJ; Ulloa L
    Nat Med; 2004 Nov; 10(11):1216-21. PubMed ID: 15502843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
    Pavlov VA; Ochani M; Yang LH; Gallowitsch-Puerta M; Ochani K; Lin X; Levi J; Parrish WR; Rosas-Ballina M; Czura CJ; Larosa GJ; Miller EJ; Tracey KJ; Al-Abed Y
    Crit Care Med; 2007 Apr; 35(4):1139-44. PubMed ID: 17334244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuronal strategy for inflammation.
    Ulloa L; Wang P
    Novartis Found Symp; 2007; 280():223-33; discussion 233-7. PubMed ID: 17380797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can nicotine treat sepsis?
    Matthay MA; Ware LB
    Nat Med; 2004 Nov; 10(11):1161-2. PubMed ID: 15516907
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine attenuates inflammatory response in macrophages and improves survival in experimental model of sepsis through heme oxygenase-1 induction.
    Tsoyi K; Jang HJ; Kim JW; Chang HK; Lee YS; Pae HO; Kim HJ; Seo HG; Lee JH; Chung HT; Chang KC
    Antioxid Redox Signal; 2011 Jun; 14(11):2057-70. PubMed ID: 21083424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.
    Wang H; Yu M; Ochani M; Amella CA; Tanovic M; Susarla S; Li JH; Wang H; Yang H; Ulloa L; Al-Abed Y; Czura CJ; Tracey KJ
    Nature; 2003 Jan; 421(6921):384-8. PubMed ID: 12508119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis.
    Huston JM; Gallowitsch-Puerta M; Ochani M; Ochani K; Yuan R; Rosas-Ballina M; Ashok M; Goldstein RS; Chavan S; Pavlov VA; Metz CN; Yang H; Czura CJ; Wang H; Tracey KJ
    Crit Care Med; 2007 Dec; 35(12):2762-8. PubMed ID: 17901837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling.
    Parrish WR; Rosas-Ballina M; Gallowitsch-Puerta M; Ochani M; Ochani K; Yang LH; Hudson L; Lin X; Patel N; Johnson SM; Chavan S; Goldstein RS; Czura CJ; Miller EJ; Al-Abed Y; Tracey KJ; Pavlov VA
    Mol Med; 2008; 14(9-10):567-74. PubMed ID: 18584048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of alpha 7 cholinergic receptors inhibits lipopolysaccharide-induced neutrophil recruitment by a tumor necrosis factor alpha-independent mechanism.
    Giebelen IA; van Westerloo DJ; LaRosa GJ; de Vos AF; van der Poll T
    Shock; 2007 Apr; 27(4):443-7. PubMed ID: 17414429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors.
    Shytle RD; Mori T; Townsend K; Vendrame M; Sun N; Zeng J; Ehrhart J; Silver AA; Sanberg PR; Tan J
    J Neurochem; 2004 Apr; 89(2):337-43. PubMed ID: 15056277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role.
    Suzuki T; Hide I; Matsubara A; Hama C; Harada K; Miyano K; Andrä M; Matsubayashi H; Sakai N; Kohsaka S; Inoue K; Nakata Y
    J Neurosci Res; 2006 Jun; 83(8):1461-70. PubMed ID: 16652343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cholinergic agonist attenuates endotoxin-induced uveitis in rats.
    Chi ZL; Hayasaka S; Zhang XY; Cui HS; Hayasaka Y
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2719-25. PubMed ID: 17525204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
    Tang Y; Lv B; Wang H; Xiao X; Zuo X
    Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung.
    Giebelen IA; van Westerloo DJ; LaRosa GJ; de Vos AF; van der Poll T
    Shock; 2007 Dec; 28(6):700-3. PubMed ID: 17621262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of alpha7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes.
    Hamano R; Takahashi HK; Iwagaki H; Yoshino T; Nishibori M; Tanaka N
    Shock; 2006 Oct; 26(4):358-64. PubMed ID: 16980882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality.
    Pan P; Cardinal J; Dhupar R; Rosengart MR; Lotze MT; Geller DA; Billiar TR; Tsung A
    J Leukoc Biol; 2009 Sep; 86(3):625-32. PubMed ID: 19487305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vagus nerve and the nicotinic anti-inflammatory pathway.
    Ulloa L
    Nat Rev Drug Discov; 2005 Aug; 4(8):673-84. PubMed ID: 16056392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis.
    van Westerloo DJ; Giebelen IA; Florquin S; Daalhuisen J; Bruno MJ; de Vos AF; Tracey KJ; van der Poll T
    J Infect Dis; 2005 Jun; 191(12):2138-48. PubMed ID: 15898001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in high mobility group box-1 protein mediated multiple organ dysfunction and its potential interventional strategies].
    Yao YM; Xu S; Sheng ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Aug; 29(4):459-65. PubMed ID: 19209785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway.
    Kim JH; Kim SJ; Lee IS; Lee MS; Uematsu S; Akira S; Oh KI
    J Immunol; 2009 Feb; 182(4):2458-66. PubMed ID: 19201901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.